Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Sun Pharmaceutical Industries Ltd.
NSE: SUNPHARMA
|
BSE: 524715
|
ISIN: INE044A01036
|
Industry: Pharmaceuticals
US FDA Classification
|
Mid-range Performer
1609.7000
16.30
(
1.02
%)
NSE
Sep 11, 2025
15:31 PM
Near 52W Low of ₹1553.05
Volume:
1.8M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Sun Pharmaceutical Industries Ltd.
31 May 2023
US FDA Classification
1609.70
1.02%
SUN PHARMA
Buy:
Sun Pharmaceutical Industr...
by
Geojit BNP Paribas
Target: 1101
Recommendation
Target
Geojit BNP Paribas
Sun Pharmaceutical I.. has an
average target
of 2050.25 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal
Trendlyne Marketwatch |
11 Sep 2025, 04:07PM
India’s IPO story in 2025: Investors go selective, backing quality over hype
The Baseline |
11 Sep 2025, 03:50PM
Change is hard, and some Indian pharma companies are embracing it better than others
|
09 Aug 2022